Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y266-p , Y368-p , Y449-p
Akt1 S616-p
AMPKA1 S637-p
CDK1 S616-p
CDK5 S616-p
ERK1 S616-p
ERK2 S616-p
GSK3B S40-p , S44-p , S616-p , S693-p
LRRK2 T595-p
Pim1 S637-p
PKACA S637-p
PKCD S616-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Abl Y266-p , Y368-p , Y449-p
CDK1 S616-p
CDK2 S616-p
ERK1 S616-p
ERK2 S616-p
GSK3B S40-p , S44-p , S693-p
LRRK2 T595-p
PKACA S637-p
PRKD1 S637-p
Phosphatases, in vitro:
PGAM5 S637-p
PPP2R5C S616-p
PPP3CA S637-p
Regulatory protein:
AMPKA1 S637-p
ASNS S616-p , S637-p
BLOC1S1 S616-p , S637-p
BORIS S616-p
caveolin-1 S637-p
CDK5R1 S616-p
CDK5 S637-p
CNR1 S616-p , S637-p
CPT1A S616-p , S637-p
CUL4A S616-p , S637-p
DAP3 S616-p , S637-p
DDAH2 S616-p
DDB1 S616-p , S637-p
DRP1 S616-p
ERK1 S616-p
FUNDC1 S616-p
HIF1A S616-p
HMGB1 S616-p , S637-p
HSP90A S637-p
KIF1B S637-p
LCN2 S616-p
LIMK2 S616-p , S637-p
LMP1 S616-p
MEK1 S616-p , S637-p
MLXIP S616-p
MYH9 S616-p
MYO1F S616-p
NuaK1 S616-p
OTUB1 S616-p
PARK2 S616-p
PGAM5 S616-p
PIEZO1 S616-p , S637-p
Pim1 S616-p
PKCD S616-p
PPP2R5C S616-p
PRDX3 S616-p
PRSS15 S616-p
PXN S616-p
RAB20 S637-p
RAB32 S616-p , S637-p
RALA S616-p
RALBP1 S616-p
RAP2C S637-p
Raptor S616-p
ROCK1 S637-p
SHP-2 S616-p
SIRT1 S637-p
SIRT3 S637-p
SIRT6 S616-p
Src S616-p
STMP1 S616-p , S637-p
streptavidin S616-p
TNFAIP8L3 S637-p
Treatment:
ARCC-4 S616-p
(S)-lacosamide S616-p
3-(2-Aminoethyl)-5-((4-ethoxyphenyl)methylene)-2,4-thiazolidinedione, HCl S616-p
A769662 S616-p
acadesine S637-p
ACEA S637-p
adriamycin S616-p , S637-p
anandamide S616-p , S637-p
antimycin_A S616-p , S637-p
apalutamide S616-p
arachidonic_acid S637-p
AZD1208 S616-p , S637-p
bacterial infection S616-p
BI2536 S724-p
butaprost S616-p , S637-p
cAMP_analog S637-p
carnitine S616-p
CCCP S616-p , S637-p
celastrol S637-p
ciclosporin S637-p
cisplatin S616-p , S637-p
CoCl2 S616-p , S637-p
coculture S616-p , S637-p
colforsin S637-p
compound_C S637-p
copper S616-p
crenolanib S637-p
CsA S616-p
Cucurbitacin-E S616-p , S637-p
dasatinib S616-p
deltaV1-1 S616-p
development S616-p
docetaxel S616-p , S637-p
doxycycline S616-p , S637-p
Dynasore S616-p , S637-p
enzalutamide S616-p
Erastin S637-p
erucin S637-p
etomoxir S616-p
exercise training S616-p
FCCP S637-p
FK506 S637-p
FK866 S637-p
flavopiridol S616-p , S637-p
fluorouracil S616-p
fungal infection S616-p , S637-p
G-1 S616-p
GSK621 S637-p
H-89 S616-p , S637-p
H2O2 S616-p
hexafluoro S616-p
honokiol DCA S616-p
hypothermia S616-p , S637-p
hypoxia S616-p , S637-p
hypoxia/reoxygenation S616-p
IBMX S637-p
IgE S616-p
IL-27 S637-p
ionomycin S616-p , S637-p
ischemia S548-p , S616-p
JAK_inhibitor_I T394-p
KB SRC 4 S616-p
KN-93 S616-p
L-glutamine_withdrawal S616-p , S637-p
LCB 03-0100 S616-p
LIGHT S616-p
light S616-p , S637-p
lithium S693-p
lncRNAs S616-p , S637-p
LPS S616-p
LRRK2-IN-1 S616-p
luteolin S616-p
Mdivi-1 S616-p , S637-p
MEK_inhibitor_I T394-p
melatonin S616-p
metformin S616-p , S637-p
MPTP S616-p
MRE-269 S616-p , S637-p
NAC S616-p
NaIO3 S616-p
NGF_withdrawal S637-p
nicotinamide S616-p , S637-p
NKH_477 S637-p
nocodazole S616-p , S637-p
obesity S616-p
odanacatib S616-p
OGD/R S616-p , S637-p
oleic_acid S616-p , S637-p
P110 T595-p
palmitate S616-p , S637-p
PD0325901 S616-p , S637-p
PD98059 S616-p
PDGF S616-p
PF04418948 S616-p , S637-p
PIM447 S616-p , S637-p
pirinixic acid S616-p , S637-p
R03306 S616-p
RO-3306 S616-p
RO1138452 S616-p , S637-p
rotenone S616-p , S637-p
sanglifehrin A S637-p
SB525334 S616-p
SCH772984 S616-p
seliciclib S616-p
selisistat S637-p
serum S616-p
sevoflurane S616-p , S637-p
Shenmai S616-p , S637-p
siRNA S616-p , S637-p
sirtinol S637-p
SRT1720 S637-p
starvation S616-p
status epilepticus S616-p , S637-p
stiff ECM substrate S616-p , S637-p
substance_P S616-p
tamoxifen S616-p , S637-p
TDZD-8 S616-p
TGF-beta S616-p , S637-p
TNF S616-p
Trametinib S616-p
Treprostinil S616-p , S637-p
Trolox S616-p
U0126 S616-p
unilateral ureteral obstruction S616-p , S637-p
virus infection S616-p
Wnt3a S616-p , S637-p
Y27632 S616-p , S637-p